Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
189353-81-9
|
| gptkbp:developedBy |
gptkb:AstraZeneca
|
| gptkbp:drugClass |
gptkb:enzyme
|
| gptkbp:hasInChIKey |
QZJZQKZQKZQKZQ-UHFFFAOYSA-N
InChI=1S/C16H19N3O2S/c1-18(2)10-11-21-14-6-8-15(9-7-14)19-16(20)13-5-3-4-12-22-13/h3-9,12H,10-11H2,1-2H3,(H,19,20) |
| gptkbp:hasMolecularFormula |
C16H19N3O2
|
| gptkbp:hasSMILES |
CN(C)CCOC1=CC=C(C=C1)NC(=O)C2=CC=CS2
|
| https://www.w3.org/2000/01/rdf-schema#label |
AZD7545
|
| gptkbp:IUPACName |
N-(4-(2-(dimethylamino)ethoxy)phenyl)-2-thiophenecarboxamide
|
| gptkbp:mechanismOfAction |
pyruvate dehydrogenase kinase inhibitor
|
| gptkbp:molecularWeight |
285.34 g/mol
|
| gptkbp:PubChem_CID |
9942222
CHEMBL2037 |
| gptkbp:research_use |
investigational drug
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
N-(4-(2-(dimethylamino)ethoxy)phenyl)-2-thiophenecarboxamide
|
| gptkbp:target |
pyruvate dehydrogenase kinase
|
| gptkbp:bfsParent |
gptkb:PDK2
|
| gptkbp:bfsLayer |
7
|